Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. [electronic resource]
Producer: 19990903Description: 268-76 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Immunoglobulins -- analysis
- Lymphoma, B-Cell -- genetics
- Lymphoma, Non-Hodgkin -- genetics
- Male
- Middle Aged
- Polymerase Chain Reaction
- Prednisone -- administration & dosage
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Rituximab
- Translocation, Genetic
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.